Grants paid by Vhl Alliance Inc
EIN 04-3180414 · Boston, MA · Form 990, Schedule I · NTEE E20Z
Vhl Alliance Inc of Boston, MA (EIN 04-3180414) reported 4 grants paid totaling $166,667 to 4 recipients in tax years 2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$166,667
4 grants
Recipients
4
distinct organizations
Tax years
2024
1 filing in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2024 | 4 | $166,667 | — |
Top recipients
The 4 recipients receiving the most from Vhl Alliance Inc, by grants paid, out of 4 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| University of Texas Health Science Center at San Antonio | U | San Antonio, TX | 1 | $50,000 | 2024 |
| University of Utah 87-6000525 | B | Salt Lake City, UT | 1 | $50,000 | 2024 |
| University of Notre Dame 52-1539710 | B | Notre Dame, IN | 1 | $50,000 | 2024 |
| Md Anderson Cancer Center | U | Houston, TX | 1 | $16,667 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 4 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | University of Notre Dame Notre Dame, IN | B | $50,000 | paid | SYNTHETIC ESSENTIALITY OF TRAIL/TNFSF10 IN VHL-DEFICIENT RENAL CELL CARCINOMA | 202443209349318839 |
| 2024 | University of Utah Salt Lake City, UT | B | $50,000 | paid | NEUROFIBROMIN STABILIZATION AS A TREATMENT STRATEGY FOR VHL DISEASE | 202443209349318839 |
| 2024 | University of Texas Health Science Center at San Antonio San Antonio, TX | U | $50,000 | paid | VHL RELATED PHEOCHROMOCYTOMAS STUDY | 202443209349318839 |
| 2024 | Md Anderson Cancer Center Houston, TX | U | $16,667 | paid | IMMUNE MODULATION IN VON HIPPELLINDAU DISEASE BY TARGETING THE DNA DAMAGE RESPONSE NETWORK | 202443209349318839 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2024 | 2024-06-30 | not stated | 2023v5.1 | 202443209349318839 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/043180414.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.